Perpetual Ltd decreased its stake in Afya Limited (NASDAQ:AFYA - Free Report) by 26.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 148,450 shares of the company's stock after selling 53,816 shares during the period. Perpetual Ltd owned 0.16% of Afya worth $2,662,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Public Employees Retirement System of Ohio increased its stake in shares of Afya by 40.0% in the fourth quarter. Public Employees Retirement System of Ohio now owns 2,800 shares of the company's stock valued at $44,000 after buying an additional 800 shares during the period. Jane Street Group LLC boosted its position in shares of Afya by 3.7% during the 4th quarter. Jane Street Group LLC now owns 56,341 shares of the company's stock valued at $895,000 after purchasing an additional 2,032 shares in the last quarter. Dodge & Cox boosted its position in shares of Afya by 7.1% during the 4th quarter. Dodge & Cox now owns 31,262 shares of the company's stock valued at $496,000 after purchasing an additional 2,079 shares in the last quarter. Aquatic Capital Management LLC boosted its position in shares of Afya by 47.6% during the 4th quarter. Aquatic Capital Management LLC now owns 9,300 shares of the company's stock valued at $148,000 after purchasing an additional 3,000 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in shares of Afya by 1,099.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 4,031 shares of the company's stock valued at $64,000 after purchasing an additional 3,695 shares in the last quarter. Institutional investors and hedge funds own 88.02% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on AFYA shares. Morgan Stanley lowered Afya from an "equal weight" rating to an "underweight" rating and cut their target price for the company from $19.00 to $17.00 in a research report on Tuesday, March 11th. UBS Group restated a "neutral" rating and set a $19.50 target price (up previously from $17.50) on shares of Afya in a research report on Thursday, June 12th. Finally, Wall Street Zen upgraded Afya from a "hold" rating to a "buy" rating in a research report on Saturday, June 14th. Three analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. According to MarketBeat, Afya currently has an average rating of "Hold" and an average target price of $17.60.
Get Our Latest Report on Afya
Afya Stock Down 0.3%
NASDAQ:AFYA traded down $0.05 on Friday, hitting $17.57. The stock had a trading volume of 39,521 shares, compared to its average volume of 122,534. The business's fifty day moving average is $18.46 and its 200 day moving average is $17.27. The company has a market cap of $1.65 billion, a PE ratio of 13.31, a P/E/G ratio of 0.60 and a beta of 0.60. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.41. Afya Limited has a 52 week low of $14.52 and a 52 week high of $19.90.
About Afya
(
Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Read More

Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.